Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

FTSE 100 snaps four-day winning streak as Britain’s Ocado slumps

by Staff GBAF Publications Ltd
0 comment

By Johann M Cherian and Shashwat Chauhan

(Reuters) -UK’s blue-chip index closed lower on Tuesday, ending a four-day winning streak after weak economic data from China raised concerns about global growth, while shares of Ocado Group slumped after disappointing results.

The FTSE 100 dipped 0.1% to 7,851.0, hovering below its record high of 7,903.5 hit in May 2018, while the domestically-focused FTSE 250 shed 0.7%.

Ocado Group tumbled 9.3% after online supermarket Ocado Retail warned it would not return to profit until the second half of its financial year.

Drugmaker AstraZeneca dropped 0.7%, while consumer company Unilever fell 1.5% after Bernstein downgraded the stock to “underperform”.

“This looks like a temporary interruption to the index’s victorious progress however – the trading statement season has gone well so far for UK firms, providing a foundation for further gains in the near-term,” said Chris Beauchamp, chief market analyst at online trading platform IG.

Data showed pay growth in Britain – which is being closely watched by the Bank of England as it gauges how much higher to raise interest rates – gained pace in the three months to November, official data showed.

Asia-focused bank HSBC and insurer Prudential slipped 0.8% and 0.4%, respectively, after data showed China’s economic growth in 2022 slumped to one of its weakest in nearly half a century.

“Despite our less optimistic view on earnings we think that lower energy costs, the reopening of China and lower rates volatility will be supportive for equity valuations,” said Maximilian Uleer, senior strategist at Deutsche Bank Research.

“We are positive for equity markets in 2023 and have a year-end target of 8,200 for the FTSE 100.”

The benchmark outperformed major global stock indexes last year, riding a surge in commodity prices. The midcaps, however, fell the most since the global financial crisis, hit by a severe cost-of-living crisis and weak economic growth.

(Reporting by Johann M Cherian and Shashwat Chauhan in Bengaluru; Editing by Saumyadeb Chakrabarty, Shailesh Kuber and Tomasz Janowski)